2- 3 the various parts of such registration statements, including all exhibits thereto and the documents incorporated by reference in the prospectus contained in such registration statements at the time such part of such registration statements became...Distribution Agreement • October 23rd, 1997 • Merck & Co Inc • Pharmaceutical preparations • New York
MERCK & CO., INC.First Supplemental Indenture • September 25th, 1997 • Merck & Co Inc • Pharmaceutical preparations • New York
EXHIBIT 2 AGREEMENT AND PLAN OF MERGERMerger Agreement • May 10th, 2000 • Merck & Co Inc • Pharmaceutical preparations • Delaware
1 EXHIBIT 3 STOCK OPTION AGREEMENT STOCK OPTION AGREEMENT, dated as of July 30, 1999 (the "Agreement"), among Merck & Co., Inc., a New Jersey corporation (the "Grantee"), MC Subsidiary Corp., a Delaware corporation and a wholly owned subsidiary of the...Stock Option Agreement • August 6th, 1999 • Merck & Co Inc • Pharmaceutical preparations • Delaware
RECITALNon-Qualified Stock Option Agreement • March 20th, 1996 • Merck & Co Inc • Pharmaceutical preparations • New Jersey
EXHIBIT 1 MERCK & CO., INC. MEDIUM-TERM NOTES, SERIES F DISTRIBUTION AGREEMENTDistribution Agreement • January 13th, 2005 • Merck & Co Inc • Pharmaceutical preparations • New York
OFLimited Liability Company Agreement • March 23rd, 2001 • Merck & Co Inc • Pharmaceutical preparations • Delaware
Exhibit 1.1 MERCK & CO., INC. DEBT SECURITIES UNDERWRITING AGREEMENTUnderwriting Agreement • February 13th, 2003 • Merck & Co Inc • Pharmaceutical preparations • New York
JOINT FILING AGREEMENTJoint Filing Agreement • May 10th, 2000 • Merck & Co Inc • Pharmaceutical preparations
EXHIBIT 3 STOCKHOLDER AGREEMENT STOCKHOLDER AGREEMENT (this "Agreement") dated as of May 4, 2000 among ShopKo Stores, Inc., a Wisconsin corporation, SKO Holdings, Inc. a Delaware corporation and a wholly owned subsidiary of ShopKo Stores, Inc....Stockholder Agreement • May 10th, 2000 • Merck & Co Inc • Pharmaceutical preparations • Delaware
1 EXHIBIT 2 SHAREHOLDERS AGREEMENT SHAREHOLDERS AGREEMENT (this "Agreement") dated as of July 30, 1999 among the persons listed on Schedule 1 hereto (each, a "Holder" and, collectively, the "Holders"), Merck & Co., Inc., a New Jersey corporation...Shareholders Agreement • August 6th, 1999 • Merck & Co Inc • Pharmaceutical preparations • Delaware
EXHIBIT 99.(d)(6) FIRST AMENDMENT TO RIGHTS AGREEMENT AMENDMENT made and entered into as of the 4th day of May, 2000, by and between ProVantage Health Services, Inc. (the "Company") and Norwest Bank Minnesota, National Association (the "Right Agent"),...Rights Agreement • May 10th, 2000 • Merck & Co Inc • Pharmaceutical preparations • Delaware
RECITALSEmployment Agreement • May 10th, 2000 • Merck & Co Inc • Pharmaceutical preparations • New Jersey
BY AND AMONGMerger Agreement • May 21st, 2001 • Merck & Co Inc • Pharmaceutical preparations • Delaware
AMENDMENTLease Agreement • May 10th, 2000 • Merck & Co Inc • Pharmaceutical preparations
2- 3 contained in the latest registration statement, to the Representatives for each of the other Underwriters, have been declared effective by the Commission in such form; other than a Registration Statement, if any, increasing the size of the...Underwriting Agreement • May 3rd, 1999 • Merck & Co Inc • Pharmaceutical preparations • New York
EXHIBIT 99.(d)(12) CONFIDENTIALITY AGREEMENT ------------------------- THIS CONFIDENTIALITY AGREEMENT (this "Agreement") is made as of this 8th day of December, 1999 between PROVANTAGE HEALTH SERVICES, INC., a Delaware corporation with its principal...Confidentiality Agreement • May 10th, 2000 • Merck & Co Inc • Pharmaceutical preparations • Wisconsin
JOINT FILING AGREEMENTJoint Filing Agreement • August 6th, 1999 • Merck & Co Inc • Pharmaceutical preparations
WHEREAS, Merck-Medco, the Employee and certain other members have entered into a Limited Liability Corporation Agreement, dated as of November 27, 2000 (the "LLC Agreement"), pursuant to which the Employee will become a member ------------- of Merck...Employment Agreement • March 23rd, 2001 • Merck & Co Inc • Pharmaceutical preparations • New Jersey
2- 3 the Commission under the Act), each in the form heretofore delivered to the Representatives on or prior to the date hereof; and no stop order suspending the effectiveness of the Initial Registration Statement, any post- effective amendment...Underwriting Agreement • September 25th, 1997 • Merck & Co Inc • Pharmaceutical preparations • New York
AGREEMENT AND PLAN OF MERGER by and among MERCK & CO., INC., SPINNAKER ACQUISITION CORP. a wholly owned subsidiary of MERCK & CO., INC. and SIRNA THERAPEUTICS, INC. Dated as of October 30, 2006Merger Agreement • November 3rd, 2006 • Merck & Co Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of October 30, 2006, by and among MERCK & CO., INC., a New Jersey corporation (“Parent”), SPINNAKER ACQUISITION CORP., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and SIRNA THERAPEUTICS, INC., a Delaware corporation (the “Company”).
MERCK & CO., INC. DEBT SECURITIES UNDERWRITING AGREEMENTUnderwriting Agreement • August 13th, 2004 • Merck & Co Inc • Pharmaceutical preparations • New York
Designated Securities are repayable on , [insert date and years], at the option of the holder, at their principal amount with accrued interest. The initial annual interest rate will be %, and thereafter the annual interest rate will be adjusted on , and to a rate not less than % of the effective annual interest rate on U.S. Treasury obligations with -year maturities as of the [insert date 15 days prior to maturity date] prior to such [insert maturity date].]
REGISTERED REGISTERED No. FXR-______________ PRINCIPAL CUSIP No.: _______________ AMOUNT (and Specified Currencies if other than U.S. dollars):Medium-Term Note Agreement • January 13th, 2005 • Merck & Co Inc • Pharmaceutical preparations
Reference is made to the Agreement and Plan of Merger, dated as of the date hereof (the "Merger Agreement"), by and between Merck & Co., Inc., a New ---------------- Jersey corporation ("Parent"), PV Acquisition Corp., a Delaware corporation and...Side Letter • May 10th, 2000 • Merck & Co Inc • Pharmaceutical preparations
1Q `01 1Q `00 % CHG. ---------------------------------------------------------- ----------------------Financial Report • April 20th, 2001 • Merck & Co Inc • Pharmaceutical preparations
BETWEEN ASTRA AB ANDLicense and Option Agreement • August 12th, 1998 • Merck & Co Inc • Pharmaceutical preparations • New York
2- 3 (b) The Option may be exercised by Parent, in whole (but not in part), if after the date hereof the Merger Agreement shall be terminated pursuant to:Voting and Stock Option Agreement • May 21st, 2001 • Merck & Co Inc • Pharmaceutical preparations • Delaware
Underwriting AgreementUnderwriting Agreement • February 23rd, 2005 • Merck & Co Inc • Pharmaceutical preparations • New York
From time to time Merck & Co., Inc., a New Jersey corporation (the “Company”), proposes to enter into one or more Pricing Agreements (each a “Pricing Agreement”) in the form of Annex I hereto, with such additions and deletions as the parties thereto may determine, and, subject to the terms and conditions stated herein and therein, to issue and sell to the firms named in Schedule I to the applicable Pricing Agreement (such firms constituting the “Underwriters” with respect to such Pricing Agreement and the securities specified therein) certain of its debt securities (the “Securities”) specified in Schedule II to such Pricing Agreement (with respect to such Pricing Agreement, the “Designated Securities”).
1 AGREEMENT FOR PURCHASE AND SALE OF SECURITIES THIS AGREEMENT FOR PURCHASE AND SALE OF SECURITIES (the "Agreement") is made and entered into this 25th day of September, 1998, by and between Merck-Medco Managed Care, L.L.C., a Delaware limited...Purchase and Sale of Securities • September 25th, 1998 • Merck & Co Inc • Pharmaceutical preparations • Delaware
BetweenSupply Agreement • August 12th, 1998 • Merck & Co Inc • Pharmaceutical preparations • New York
AGREEMENT AND PLAN OF MERGER by and among MERCK & CO., INC., SCHERING-PLOUGH CORPORATION, BLUE, INC., and PURPLE, INC. March 8, 2009Merger Agreement • March 10th, 2009 • Merck & Co Inc • Pharmaceutical preparations
THIS AGREEMENT AND PLAN OF MERGER is made as of March 8, 2009, by and among Merck & Co., Inc., a New Jersey corporation (“Mercury”), Schering-Plough Corporation, a New Jersey corporation (“Saturn”), Blue, Inc., a New Jersey corporation and a wholly owned subsidiary of Saturn (“Merger Sub 1”), and Purple, Inc., a New Jersey corporation and a wholly owned subsidiary of Saturn (“Merger Sub 2”). Capitalized terms used and not otherwise defined in this Agreement have the meanings set forth in Article IX.
DESIGNATED LIBOR DESIGNATED CMT PAGE: MATURITY INDEX:Medium-Term Note Agreement • January 13th, 2005 • Merck & Co Inc • Pharmaceutical preparations
1 EXHIBIT (c)(4) CONFIDENTIAL DISCLOSURE AGREEMENT This Agreement (the "Agreement") is entered into as of this 23rd day of June 1999 by and between SIBIA Neurosciences, Inc., having a business address of 505 Coast Boulevard South, Suite 300, La Jolla,...Confidentiality Agreement • August 6th, 1999 • Merck & Co Inc • Pharmaceutical preparations • California
WITNESSETH:Agreement to Incorporate Defined Terms • August 12th, 1998 • Merck & Co Inc • Pharmaceutical preparations
RECITALSTax Matters Agreement • May 10th, 2000 • Merck & Co Inc • Pharmaceutical preparations • Wisconsin
